Dan Rujescu

Head of Clinical Division of General Psychiatry

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Dan Rujescu is the Head of the Clinical Division of General Psychiatry at the Medical University of Vienna, Austria. His research focuses on the interplay between the serotonergic system and emotion processing, Alzheimer disease biomarkers, and the genetic diversity of major psychiatric disorders. He has contributed significantly to the understanding of the relationship between mild motor signs, depression, and medication effects among other areas of study.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Collaborators (8)

Andreas Simm

University Hospital Halle (Saale)

GERMANY

View details

Andreas Hahn

Associate Professor

Medical University of Vienna

AUSTRIA

View details

Siegfried Kasper

Professor and Chair

Medical University of Vienna

AUSTRIA

View details

Leo Silberbauer

Medical University of Vienna

AUSTRIA

View details

Giuseppe Fanelli

Junior assistant professor (fixed-term)

University of Bologna

ITALY

View details

Antonina Luca

Professore Associato

Università degli Studi di Enna Kore

ITALY

View details

Daniel Souery

Head

BELGIUM

View details

Rupert Lanzenberger

Prof. P.D. M.D.

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dan Rujescu

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A large-scale multimodal investigation of the interplay between the serotonergic system and emotion processing

Correction: Mild motor signs and depression: more than just medication side effects?

Association of Nonmodifiable Risk Factors With Alzheimer Disease Blood Biomarkers in Community-Dwelling Adults in the ESTHER Study

Mild motor signs and depression: more than just medication side effects?

Mitochondrial DNA abundance in blood is associated with Alzheimer’s disease- and dementia-risk

Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease—A Feasibility Study

Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: A molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs)

Reply to: “The serotonin theory of depression: a systematic umbrella review of the evidence” published by Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA in Molecular Psychiatry (2022 Jul 20. doi: 10.1038/s41380-022-01661-0)

Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo

Prescriptions of psychopharmacologic drugs in Austria in 2019 and 2020 – Implications of the COVID-19 pandemic

Collaborators (8)

Andreas Simm

Andreas Hahn

Siegfried Kasper

Leo Silberbauer

Giuseppe Fanelli

Antonina Luca

Daniel Souery

Rupert Lanzenberger

Make your next move.